Financial Overview
Cash received in Lilly collaboration $110 M
Upfront payments - $80M
Equity purchased - $30M ($18.69/share)
Cash expenditures for 3Q 2002: $26 M
Cash at end of 3Q 2002: $180 M
Estimated cash burn for 4Q 2002: >$30 M
Previous slide
Next slide
Back to first slide
View graphic version